1OWild-type KRAS mediates growth inhibition and resistance to MEK inhibitors through dimerization with mutant KRAS in lung adenocarcinomaC. Ambrogio,J. Kohler,Z. Zhou,H. Wang, R. Paranal,M. Capelletti, C. Caffarra,S. Li, Q. Lv,D. Santamaria,K.D. Westover,Pasi A. JänneAnnals of Oncology(2017)引用 4|浏览19暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要